Tuncay Göksel

Researcher Next ID · RN-010005

Researcher · Medicine

, Turkey

Not currently recruitingFunding unknown

Research interests

Medicine

Engineering

Lung Cancer Treatments and Mutations

Lung Cancer Diagnosis and Treatment

Lung Cancer Research Studies

Biosensors and Analytical Detection

Advanced Chemical Sensor Technologies

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer
JAMA · 2022 · 10.1001/jama.2022.16464
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
The Lancet Oncology · 2020 · 10.1016/s1470-2045(20)30539-8
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
The Lancet · 2019 · 10.1016/s0140-6736(18)32409-7
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
The Lancet · 2014 · 10.1016/s0140-6736(14)60845-x
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
Journal of Clinical Oncology · 2008 · 10.1200/jco.2007.15.0375

No projects listed.